Charous gets 483 for failing to follow investigational plan.(Clinical investigators)

Bruce Charous, M.D., Milwaukee, WI, received a one-item 483 because he failed to follow the investigational plan in that the protocol was not completely followed for some study subjects.

Investigator Denise Burosh from the Minneapolis, MN, District Office conducted the inspection.

"A complete medical history specifically related to COPD was not obtained for these two subjects at the time of screening," the EIR stated. Also, one adverse event was not reported as required by section 9.1 of the protocol. Specifically, during visit 12, the physical for one subject identified a significant change from baseline for the eyes due to allergies.

The EIR also noted that it could not be determined from the information in the source documents whether certain subjects had been fully evaluated for acceptance into the study. "The clinical investigator did not document obtained information on the subject's medical history."

Also, it stated that there was no documentation on who was treating the subject for COPD, who diagnosed COPD, what the subject's symptoms when stable versus sick were, and any relevant environmental or occupational exposure symptoms. Further, there was no detailed assessment of history of COPD exacerbations including changes in treatment and types of medical contact.

Concerning another subject, the only source document information on medical history at the time of screening was the source document worksheet, as well as current treatment information for the subject's ongoing yeast/vaginal infection.

"The protocol requires that all untoward medical occurrences in a subject that is receiving the study drug be recorded. An adverse event for [one subject] that had an abnormal eye condition due to allergies identified at the final visit did not have allergies at the screening visit. All adverse events whether or not related to or caused by the study drug are to be reported," according to the document.

Management agreed that for non-clinical subjects that did not provide outside medical history records, that they must document detailed information provided by the patient in the source documents.

"Charous stated that when he determines, based on the physical and discussion with the subject, to enter the subject into the study, he will document his reasons why the subject is eligible and the required protocol medical history information in the notes."

Management also agreed that they should have reported an adverse event for the subject at the time of the final visit due to the change in medical history from the screening visit. "They stated that they will make an extra effort to make sure all adverse events such as this one are reported," the EIR stated.

The doctor could not be reached for comment. Bruce Charous, M.D., Milwaukee, WI, 11/6-13/06, Doc. 115370, $5 plus retrieval.

Bruce Charous, M.D., Milwaukee, WI, Minneapolis, MN, District

Print Get the Mag Weekly Updates